| $687M | ||
| $385M | ||
| $215M | ||
| $100M | ||
| $87M | ||
| $82M |
Buys | $0 | 0 | 0 |
Sells | $1,887,320 | 1 | 100 |
| FMR LLC | See Remark 1 | 0 | $0 | 1 | $1.89M | $-1.89M |
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.
Over the last 12 months, insiders at Sana Biotechnology, Inc. have bought $0 and sold $1.89M worth of Sana Biotechnology, Inc. stock.
On average, over the past 5 years, insiders at Sana Biotechnology, Inc. have bought $6.23M and sold $2.66M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,090,909 shares for transaction amount of $6M was made by NELSEN ROBERT () on 2024‑02‑08.
| 2025-01-08 | Sale | FMR LLC | See Remark 1 | 290,912 0.1729% | $6.49 | $1.89M | -27.67% | |
| 2024-09-25 | Sale | Mulligan Richard | director | 150,000 0.0641% | $3.89 | $583,170 | -23.94% | |
| 2024-09-24 | Sale | Mulligan Richard | director | 150,000 0.0673% | $4.08 | $612,570 | -30.07% | |
| 2024-03-08 | Sale | Yang Patrick Y | director | 25,000 0.0113% | $9.45 | $236,300 | -49.05% | |
| 2024-02-08 | NELSEN ROBERT | 1.09M 0.5382% | $5.50 | $6M | -14.94% | |||
| 2024-02-08 | CRANDELL KEITH | 10 percent owner | 1.09M 0.5382% | $5.50 | $6M | -14.94% | ||
| 2024-02-08 | ARCH Venture Fund X, L.P. | 10 percent owner | 1.09M 0.5382% | $5.50 | $6M | -14.94% | ||
| 2023-12-15 | Sale | Hordo Christian | EVP, Chief Business Officer | 75,000 0.0378% | $4.00 | $300,098 | +40.90% | |
| 2023-06-07 | Sale | Flagship Ventures Fund V General Partner LLC | 10 percent owner | 200,000 0.1051% | $6.24 | $1.25M | -6.20% | |
| 2023-06-06 | Sale | Flagship Ventures Fund V General Partner LLC | 10 percent owner | 203,758 0.106% | $6.31 | $1.28M | -8.12% | |
| 2023-05-26 | Sale | Flagship Ventures Fund V General Partner LLC | 10 percent owner | 82,000 0.0425% | $6.23 | $510,573 | -7.64% | |
| 2023-05-25 | Sale | Flagship Ventures Fund V General Partner LLC | 10 percent owner | 115,372 0.0614% | $6.35 | $732,866 | -7.05% | |
| 2023-05-24 | Sale | Flagship Ventures Fund V General Partner LLC | 10 percent owner | 347,870 0.1843% | $6.57 | $2.28M | -10.34% | |
| 2022-03-21 | Yang Patrick Y | 28,000 0.016% | $7.30 | $204,400 | -19.10% | |||
| 2022-02-18 | Sale | MacDonald James J. | EVP & General Counsel | 333 0.0002% | $6.28 | $2,091 | -5.54% | |
| 2021-09-16 | Sale | AGARWAL SUNIL | EVP, Head of Development & CMO | 1,627 0.0009% | $26.00 | $42,302 | -69.16% | |
| 2021-09-15 | Sale | AGARWAL SUNIL | EVP, Head of Development & CMO | 58,373 0.0323% | $26.07 | $1.52M | -69.32% | |
| 2021-09-10 | Sale | Hordo Christian | EVP, Chief Business Officer | 1,477 0.0008% | $25.00 | $36,925 | -67.78% | |
| 2021-09-09 | Sale | Hordo Christian | EVP, Chief Business Officer | 64,671 0.0361% | $25.01 | $1.62M | -67.46% | |
| 2021-09-03 | Sale | Hordo Christian | EVP, Chief Business Officer | 700 0.0004% | $25.00 | $17,500 | -67.18% |
| FMR LLC | See Remark 1 | 4541511 1.7062% | $22.71M | 0 | 1 | |
| CRANDELL KEITH | 10 percent owner | 12446022 4.6758% | $62.23M | 1 | 0 | <0.0001% |
| NELSEN ROBERT | 12446022 4.6758% | $62.23M | 1 | 0 | <0.0001% | |
| ARCH Venture Fund X, L.P. | 10 percent owner | 12446022 4.6758% | $62.23M | 1 | 0 | <0.0001% |
| Mulligan Richard | director | 2698121 1.0136% | $13.49M | 0 | 2 | |
| AGARWAL SUNIL | EVP, Head of Development & CMO | 1550000 0.5823% | $7.75M | 0 | 2 | |
| Flagship Ventures Fund V General Partner LLC | 10 percent owner | 1380277 0.5185% | $6.9M | 0 | 5 | |
| Hordo Christian | EVP, Chief Business Officer | 867455 0.3259% | $4.34M | 0 | 7 | |
| MacDonald James J. | EVP & General Counsel | 429417 0.1613% | $2.15M | 0 | 1 | |
| Yang Patrick Y | director | 149250 0.0561% | $746,250.00 | 1 | 1 | <0.0001% |
| Bilenker Joshua H. | director | 20000 0.0075% | $100,000.00 | 1 | 0 | <0.0001% |
$21,345,882 | 83 | 94.45% | $1.57B | |
$14,874,415 | 78 | 37.43% | $1.31B | |
$1,101,324,300 | 58 | 37.37% | $1.44B | |
$613,304,943 | 46 | 11.85% | $1.28B | |
$678,065,999 | 37 | -13.32% | $1.59B | |
$530,111,731 | 35 | 8.69% | $1.28B | |
$28,907,358 | 35 | 41.41% | $1.18B | |
$31,271,604 | 28 | 28.69% | $1.19B | |
$134,557,154 | 17 | 25.14% | $1.25B | |
$276,750,010 | 16 | -7.95% | $1.22B | |
$21,945,105 | 15 | -26.51% | $1.52B | |
$154,554,190 | 14 | 29.60% | $1.52B | |
$47,458,674 | 12 | 1.73% | $1.19B | |
$93,268,646 | 8 | -37.22% | $1.23B | |
$3,200,000 | 5 | -11.36% | $1.47B | |
Sana Biotechnology, Inc. (SANA) | $18,704,399 | 5 | -20.93% | $1.33B |
$1,148,916 | 3 | -35.10% | $1.55B | |
$103,599,972 | 2 | -36.81% | $1.68B | |
$504,640 | 1 | 16.84% | $1.45B |
| Increased Positions | 115 | +78.23% | 25M | +17.65% |
| Decreased Positions | 59 | -40.14% | 7M | -4.93% |
| New Positions | 48 | New | 3M | New |
| Sold Out Positions | 20 | Sold Out | 2M | Sold Out |
| Total Postitions | 203 | +38.1% | 161M | +12.72% |
| Fmr Llc | $192,397.00 | 14.07% | 37.43M | +4M | +10.63% | 2025-09-30 |
| Flagship Pioneering Inc. | $128,510.00 | 9.4% | 25M | 0 | 0% | 2025-09-30 |
| Baillie Gifford & Co | $58,784.00 | 4.3% | 11.44M | +1M | +13.63% | 2025-09-30 |
| Blackrock, Inc. | $57,702.00 | 4.22% | 11.23M | +367,236 | +3.38% | 2025-09-30 |
| Canada Pension Plan Investment Board | $52,300.00 | 3.83% | 10.18M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $46,923.00 | 3.43% | 9.13M | +2M | +19.94% | 2025-09-30 |
| State Street Corp | $34,338.00 | 2.51% | 6.68M | +4M | +133.57% | 2025-09-30 |
| Citadel Advisors Llc | $33,677.00 | 2.46% | 6.55M | +4M | +121.72% | 2025-09-30 |
| Marex Group Plc | $19,649.00 | 1.44% | 3.82M | +5,000 | +0.13% | 2025-09-30 |
| Geode Capital Management, Llc | $17,597.00 | 1.29% | 3.42M | +143,741 | +4.38% | 2025-09-30 |